NUCLIDIUM raised €29M in a Series B round in May 2026. The company is based in Zurich, Switzerland. Investors in the round: Angelini Ventures, Aurea, Bayern Kapital and 5 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
